Skip to Main Content

Paper Details

Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Br J Haematol
17
2019
B, B-cell non-Hodgkin lymphoma, MCL, NHL, SAHA, SCR, cladribine, histone, lymphoma, mantle cell lymphoma, non-Hodgkin lymphomas, patients, rituximab, vorinostat
Author NameAffiliation
Stephen E SpurgeonCenter for Hematologic Malignancies, Knight Cancer Institute at Oregon Health & Science University
Alexander Keith StewartPenn State Hershey Cancer Institute
Motomi MoriOregon Health and Science University
  • 1 - 3

Datasets

Release 1.2